📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

SARS-CoV-2-specific memory B cells can persist in the elderly who have lost detectable neutralizing antibodies. (2022)

First Author: Jeffery-Smith A

Attributed to: Phase 1 COVID-19 Immunity - National Core Study funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1172/jci152042

PubMed Identifier: 34843448

Publication URI: http://europepmc.org/abstract/MED/34843448

Type: Journal Article/Review

Volume: 132

Parent Publication: The Journal of clinical investigation

Issue: 2

ISSN: 0021-9738